$FOLD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMICUS THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AMICUS THERAPEUTICS, INC.. Get notifications about new insider transactions in AMICUS THERAPEUTICS, INC. for free.
Page: < prev 1 ... 3 4 5 6 7 8 9 10 11 ... 28 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | SVP, Pharmacology & ... | Option Exercise | M | 2.45 | 5,000 | 12,250 | 42,500 | |
Jun 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | SVP, Pharmacology & ... | Option Exercise | M | 2.52 | 5,000 | 12,600 | 21,500 | |
Jun 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | SVP, Pharmacology & ... | Option Exercise | M | 3.53 | 5,000 | 17,650 | 15,000 | |
Jun 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | SVP, Pharmacology & ... | Option Exercise | M | 4.38 | 3,000 | 13,140 | 27,000 | |
Jun 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | SVP, Pharmacology & ... | Option Exercise | M | 4.16 | 2,500 | 10,400 | 22,500 | |
Jun 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | SVP, Pharmacology & ... | Sell | S | 13.85 | 20,500 | 284,013 | 27,687 | 48.2 K to 27.7 K (-42.54 %) |
Jun 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | SVP, Pharmacology & ... | Buy | M | 13.85 | 20,500 | 284,013 | 48,187 | 27.7 K to 48.2 K (+74.04 %) |
Jun 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | SVP, Program Manage ... | Option Exercise | M | 4.16 | 10,773 | 44,816 | 7,297 | |
Jun 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | SVP, Program Manage ... | Option Exercise | M | 3.53 | 6,264 | 22,112 | 17,502 | |
Jun 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | SVP, Program Manage ... | Option Exercise | M | 2.52 | 1,944 | 4,899 | 19,562 | |
Jun 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | SVP, Program Manage ... | Sell | S | 13.94 | 18,981 | 264,627 | 25,000 | 44 K to 25 K (-43.16 %) |
Jun 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | SVP, Program Manage ... | Buy | M | 13.94 | 18,981 | 264,627 | 43,981 | 25 K to 44 K (+75.92 %) |
Jun 24 2015 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Option Exercise | M | 2.80 | 15,000 | 42,000 | 0 | |
Jun 24 2015 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Option Exercise | M | 3.32 | 15,000 | 49,800 | 0 | |
Jun 24 2015 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Option Exercise | M | 4.79 | 15,000 | 71,850 | 0 | |
Jun 24 2015 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Option Exercise | M | 2.81 | 10,000 | 28,100 | 0 | |
Jun 24 2015 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Sell | S | 14.01 | 55,000 | 770,391 | 0 | 55 K to 0 (-100.00 %) |
Jun 24 2015 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Buy | M | 14.01 | 55,000 | 770,391 | 55,000 | 0 to 55 K |
Jun 23 2015 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | SVP, Technical Oper ... | Option Exercise | M | 2.45 | 2,812 | 6,889 | 39,376 | |
Jun 23 2015 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | SVP, Technical Oper ... | Option Exercise | M | 2.52 | 3,463 | 8,727 | 28,074 | |
Jun 23 2015 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | SVP, Technical Oper ... | Option Exercise | M | 3.53 | 2,624 | 9,263 | 22,752 | |
Jun 23 2015 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | SVP, Technical Oper ... | Option Exercise | M | 4.38 | 1,896 | 8,304 | 31,208 | |
Jun 23 2015 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | SVP, Technical Oper ... | Option Exercise | M | 4.16 | 3,250 | 13,520 | 6,500 | |
Jun 23 2015 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | SVP, Technical Oper ... | Sell | S | 13.26 | 14,045 | 186,275 | 30,688 | 44.7 K to 30.7 K (-31.40 %) |
Jun 23 2015 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | SVP, Technical Oper ... | Buy | M | 13.26 | 14,045 | 186,275 | 44,733 | 30.7 K to 44.7 K (+45.77 %) |
Jun 23 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 2.81 | 416 | 1,169 | 19,167 | |
Jun 23 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 4.16 | 12,583 | 52,345 | 12,584 | |
Jun 23 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 13.26 | 13,000 | 172,424 | 156,575 | 169.6 K to 156.6 K (-7.67 %) |
Jun 23 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 13.26 | 417 | 5,531 | 169,575 | 169.2 K to 169.6 K (+0.25 %) |
Jun 23 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 13.26 | 12,583 | 166,893 | 169,158 | 156.6 K to 169.2 K (+8.04 %) |
Jun 23 2015 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | M | 2.45 | 7,500 | 18,375 | 75,000 | |
Jun 23 2015 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | M | 2.52 | 2,655 | 6,691 | 48,879 | |
Jun 23 2015 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | M | 3.53 | 5,080 | 17,932 | 43,340 | |
Jun 23 2015 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Sell | S | 13.26 | 15,235 | 202,057 | 56,575 | 71.8 K to 56.6 K (-21.22 %) |
Jun 23 2015 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Buy | M | 13.26 | 7,500 | 99,470 | 71,810 | 64.3 K to 71.8 K (+11.66 %) |
Jun 23 2015 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Buy | M | 13.26 | 2,655 | 35,212 | 64,310 | 61.7 K to 64.3 K (+4.31 %) |
Jun 23 2015 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Buy | M | 13.26 | 5,080 | 67,375 | 61,655 | 56.6 K to 61.7 K (+8.98 %) |
Jun 16 2015 | FOLD | AMICUS THERAPEUTIC ... | Yu Julie | VP Clinical Ops & D ... | Sell | S | 14.17 | 8,195 | 116,123 | 0 | 8.2 K to 0 (-100.00 %) |
Jun 16 2015 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | SVP, Program Manage ... | Sell | S | 14.17 | 7,377 | 104,532 | 0 | 7.4 K to 0 (-100.00 %) |
Jun 12 2015 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Option Exercise | A | 13.09 | 20,000 | 261,800 | 20,000 | |
Jun 12 2015 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Option Exercise | A | 13.09 | 20,000 | 261,800 | 20,000 | |
Jun 12 2015 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Option Exercise | A | 13.09 | 20,000 | 261,800 | 20,000 | |
Jun 12 2015 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 13.09 | 20,000 | 261,800 | 20,000 | |
Jun 12 2015 | FOLD | AMICUS THERAPEUTIC ... | LOVE TED W | Director | Option Exercise | A | 13.09 | 20,000 | 261,800 | 20,000 | |
Jun 12 2015 | FOLD | AMICUS THERAPEUTIC ... | ESSNER ROBERT | Director | Option Exercise | A | 13.09 | 20,000 | 261,800 | 20,000 | |
Jun 12 2015 | FOLD | AMICUS THERAPEUTIC ... | BARER SOL J | Director | Option Exercise | A | 13.09 | 20,000 | 261,800 | 20,000 | |
Jun 09 2015 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Sell | D | 12.65 | 8,936 | 113,040 | 0 | 8.9 K to 0 (-100.00 %) |
Jun 08 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 2.81 | 55,000 | 154,550 | 0 | |
Jun 08 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 13.01 | 55,000 | 715,550 | 83,499 | 138.5 K to 83.5 K (-39.71 %) |
Jun 08 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 13.01 | 55,000 | 715,550 | 138,499 | 83.5 K to 138.5 K (+65.87 %) |
Jun 08 2015 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | SVP, Program Manage ... | Option Exercise | M | 2.45 | 14,998 | 36,745 | 30,002 | |
Jun 08 2015 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | SVP, Program Manage ... | Option Exercise | M | 2.52 | 2,314 | 5,831 | 21,506 | |
Jun 08 2015 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | SVP, Program Manage ... | Sell | S | 12.87 | 17,312 | 222,805 | 25,000 | 42.3 K to 25 K (-40.92 %) |
Jun 08 2015 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | SVP, Program Manage ... | Buy | M | 12.87 | 17,312 | 222,805 | 42,312 | 25 K to 42.3 K (+69.25 %) |
Jun 04 2015 | FOLD | AMICUS THERAPEUTIC ... | Baldry Mark | VP Global Marketing | Option Exercise | A | 12.28 | 50,000 | 614,000 | 50,000 | |
Jun 04 2015 | FOLD | AMICUS THERAPEUTIC ... | Baldry Mark | VP Global Marketing | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
Jun 03 2015 | FOLD | AMICUS THERAPEUTIC ... | Yu Julie | VP Clinical Ops & D ... | Option Exercise | A | 12.28 | 45,000 | 552,600 | 45,000 | |
Jun 03 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | SVP, Pharmacology & ... | Option Exercise | A | 12.28 | 50,000 | 614,000 | 50,000 | |
Jun 03 2015 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | VP Finance and Cont ... | Option Exercise | A | 12.28 | 45,000 | 552,600 | 45,000 | |
Jun 03 2015 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Option Exercise | A | 12.28 | 45,000 | 552,600 | 45,000 | |
Jun 03 2015 | FOLD | AMICUS THERAPEUTIC ... | Kirk John | VP, Regulatory Affa ... | Option Exercise | A | 12.28 | 45,000 | 552,600 | 45,000 | |
Jun 03 2015 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | SVP, Chief Patient ... | Option Exercise | A | 12.28 | 50,000 | 614,000 | 50,000 | |
Jun 03 2015 | FOLD | AMICUS THERAPEUTIC ... | Doshi Dipal | SVP Business Planni ... | Option Exercise | A | 12.28 | 50,000 | 614,000 | 50,000 | |
Jun 03 2015 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | A | 12.28 | 75,000 | 921,000 | 75,000 | |
Jun 03 2015 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | SVP, Technical Oper ... | Option Exercise | A | 12.28 | 50,000 | 614,000 | 50,000 | |
Jun 03 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | A | 15.96 | 230,000 | 3,670,800 | 230,000 | |
Jun 03 2015 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | SVP, Program Manage ... | Option Exercise | A | 12.28 | 50,000 | 614,000 | 50,000 | |
Jun 03 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | A | 12.28 | 100,000 | 1,228,000 | 100,000 | |
Jun 03 2015 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Option Exercise | A | 12.28 | 90,000 | 1,105,200 | 90,000 | |
Jun 03 2015 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | A | 12.28 | 90,000 | 1,105,200 | 90,000 | |
May 29 2015 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | D | 11.77 | 5 | 59 | 745,953 | 746 K to 746 K (0.00 %) |
May 13 2015 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Option Exercise | M | 0.00 | 25,000 | 0 | 25,000 | |
May 13 2015 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Payment of Exercise | F | 10.80 | 9,313 | 100,580 | 15,687 | 25 K to 15.7 K (-37.25 %) |
May 13 2015 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Buy | M | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | SVP, Pharmacology & ... | Option Exercise | M | 0.00 | 25,000 | 0 | 25,000 | |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | SVP, Pharmacology & ... | Sell | S | 10.85 | 8,000 | 86,810 | 2,687 | 10.7 K to 2.7 K (-74.86 %) |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | SVP, Pharmacology & ... | Sell | S | 10.84 | 5,000 | 54,200 | 10,687 | 15.7 K to 10.7 K (-31.87 %) |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | SVP, Pharmacology & ... | Payment of Exercise | F | 10.80 | 9,313 | 100,580 | 15,687 | 25 K to 15.7 K (-37.25 %) |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | SVP, Pharmacology & ... | Buy | M | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Yu Julie | VP Clinical Ops & D ... | Option Exercise | M | 0.00 | 25,000 | 0 | 25,000 | |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Yu Julie | VP Clinical Ops & D ... | Sell | S | 10.85 | 7,500 | 81,339 | 8,195 | 15.7 K to 8.2 K (-47.79 %) |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Yu Julie | VP Clinical Ops & D ... | Payment of Exercise | F | 10.80 | 9,305 | 100,494 | 15,695 | 25 K to 15.7 K (-37.22 %) |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Yu Julie | VP Clinical Ops & D ... | Buy | M | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | VP Finance and Cont ... | Option Exercise | M | 0.00 | 25,000 | 0 | 25,000 | |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | VP Finance and Cont ... | Sell | S | 10.84 | 7,500 | 81,306 | 8,188 | 15.7 K to 8.2 K (-47.81 %) |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | VP Finance and Cont ... | Payment of Exercise | F | 10.80 | 9,312 | 100,570 | 15,688 | 25 K to 15.7 K (-37.25 %) |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | VP Finance and Cont ... | Buy | M | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Option Exercise | M | 0.00 | 25,000 | 0 | 25,000 | |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Sell | S | 10.84 | 12,500 | 135,488 | 3,187 | 15.7 K to 3.2 K (-79.68 %) |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Payment of Exercise | F | 10.80 | 9,313 | 100,580 | 15,687 | 25 K to 15.7 K (-37.25 %) |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Buy | M | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Kirk John | VP, Regulatory Affa ... | Option Exercise | M | 0.00 | 25,000 | 0 | 25,000 | |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Kirk John | VP, Regulatory Affa ... | Sell | S | 10.84 | 10,000 | 108,358 | 5,687 | 15.7 K to 5.7 K (-63.75 %) |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Kirk John | VP, Regulatory Affa ... | Payment of Exercise | F | 10.80 | 9,313 | 100,580 | 15,687 | 25 K to 15.7 K (-37.25 %) |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Kirk John | VP, Regulatory Affa ... | Buy | M | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | SVP, Chief Patient ... | Option Exercise | M | 0.00 | 25,000 | 0 | 25,000 | |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | SVP, Chief Patient ... | Sell | S | 10.84 | 10,000 | 108,389 | 5,693 | 15.7 K to 5.7 K (-63.72 %) |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | SVP, Chief Patient ... | Payment of Exercise | F | 10.80 | 9,307 | 100,516 | 15,693 | 25 K to 15.7 K (-37.23 %) |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | SVP, Chief Patient ... | Buy | M | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | SVP, Technical Oper ... | Option Exercise | M | 0.00 | 25,000 | 0 | 25,000 | |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | SVP, Technical Oper ... | Sell | S | 10.85 | 10,000 | 108,450 | 5,688 | 15.7 K to 5.7 K (-63.74 %) |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | SVP, Technical Oper ... | Payment of Exercise | F | 10.80 | 9,312 | 100,570 | 15,688 | 25 K to 15.7 K (-37.25 %) |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | SVP, Technical Oper ... | Buy | M | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | SVP, Program Manage ... | Option Exercise | M | 0.00 | 25,000 | 0 | 25,000 | |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | SVP, Program Manage ... | Sell | S | 10.84 | 10,000 | 108,371 | 7,377 | 17.4 K to 7.4 K (-57.55 %) |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | SVP, Program Manage ... | Payment of Exercise | F | 10.80 | 7,623 | 82,328 | 17,377 | 25 K to 17.4 K (-30.49 %) |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | SVP, Program Manage ... | Buy | M | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 0.00 | 50,000 | 0 | 150,000 | |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 10.84 | 24,800 | 268,810 | 6,575 | 31.4 K to 6.6 K (-79.04 %) |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 10.80 | 18,625 | 201,150 | 31,375 | 50 K to 31.4 K (-37.25 %) |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | M | 0.00 | 50,000 | 0 | 50,000 | |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Sell | S | 10.84 | 24,800 | 268,810 | 6,575 | 31.4 K to 6.6 K (-79.04 %) |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Payment of Exercise | F | 10.80 | 18,625 | 201,150 | 31,375 | 50 K to 31.4 K (-37.25 %) |
May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Buy | M | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Apr 28 2015 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Sr Vice President D ... | Sell | D | 11.46 | 41,441 | 474,930 | 745,958 | 787.4 K to 746 K (-5.26 %) |
Apr 28 2015 | FOLD | AMICUS THERAPEUTIC ... | David Allsop | SVP International | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Apr 17 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Option Exercise | M | 4.38 | 5,000 | 21,900 | 30,000 | |
Apr 17 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Sell | S | 12.50 | 5,000 | 62,500 | 50,000 | 55 K to 50 K (-9.09 %) |
Apr 17 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Buy | M | 12.50 | 5,000 | 62,500 | 55,000 | 50 K to 55 K (+10.00 %) |
Apr 17 2015 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Option Exercise | M | 7.15 | 10,000 | 71,500 | 0 | |
Apr 17 2015 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Option Exercise | M | 7.51 | 10,000 | 75,100 | 0 | |
Apr 17 2015 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Sell | S | 12.50 | 20,000 | 250,000 | 11,933 | 31.9 K to 11.9 K (-62.63 %) |
Apr 17 2015 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Buy | M | 12.50 | 20,000 | 250,000 | 31,933 | 11.9 K to 31.9 K (+167.60 %) |
Apr 13 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.33 | 11,678 | 62,185 | 0 | |
Apr 13 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 12.00 | 11,678 | 140,136 | 83,499 | 95.2 K to 83.5 K (-12.27 %) |
Apr 13 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 12.00 | 11,678 | 140,136 | 95,177 | 83.5 K to 95.2 K (+13.99 %) |
Apr 02 2015 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | VP, Program Managem ... | Option Exercise | M | 4.16 | 5,386 | 22,406 | 18,070 | |
Apr 02 2015 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | VP, Program Managem ... | Option Exercise | M | 3.53 | 3,131 | 11,052 | 23,766 | |
Apr 02 2015 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | VP, Program Managem ... | Option Exercise | M | 2.52 | 972 | 2,449 | 23,820 | |
Apr 02 2015 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | VP, Program Managem ... | Sell | S | 10.69 | 9,489 | 101,480 | 50,000 | 59.5 K to 50 K (-15.95 %) |
Apr 02 2015 | FOLD | AMICUS THERAPEUTIC ... | Castelli Jeff | VP, Program Managem ... | Buy | M | 10.69 | 9,489 | 101,480 | 59,489 | 50 K to 59.5 K (+18.98 %) |
Mar 27 2015 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Sr Vice President D ... | Sell | D | 10.84 | 41,441 | 449,307 | 787,399 | 828.8 K to 787.4 K (-5.00 %) |
Mar 25 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Option Exercise | M | 2.52 | 3,500 | 8,820 | 26,500 | |
Mar 25 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Option Exercise | M | 5.33 | 2,000 | 10,650 | 0 | |
Mar 25 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Option Exercise | M | 0.64 | 543 | 346 | 0 | |
Mar 25 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Sell | S | 12.11 | 1,708 | 20,684 | 50,000 | 51.7 K to 50 K (-3.30 %) |
Mar 25 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Sell | S | 11.68 | 6,043 | 70,555 | 51,708 | 57.8 K to 51.7 K (-10.46 %) |
Mar 25 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Buy | M | 11.68 | 6,043 | 70,555 | 57,751 | 51.7 K to 57.8 K (+11.69 %) |
Mar 25 2015 | FOLD | AMICUS THERAPEUTIC ... | Yu Julie | VP Clinical Ops & D ... | Option Exercise | M | 2.45 | 5,611 | 13,747 | 39,389 | |
Mar 25 2015 | FOLD | AMICUS THERAPEUTIC ... | Yu Julie | VP Clinical Ops & D ... | Option Exercise | M | 2.52 | 715 | 1,802 | 9,026 | |
Mar 25 2015 | FOLD | AMICUS THERAPEUTIC ... | Yu Julie | VP Clinical Ops & D ... | Option Exercise | M | 3.53 | 1,459 | 5,150 | 8,341 | |
Mar 25 2015 | FOLD | AMICUS THERAPEUTIC ... | Yu Julie | VP Clinical Ops & D ... | Sell | S | 11.51 | 7,785 | 89,585 | 50,000 | 57.8 K to 50 K (-13.47 %) |
Mar 25 2015 | FOLD | AMICUS THERAPEUTIC ... | Yu Julie | VP Clinical Ops & D ... | Buy | M | 11.51 | 7,785 | 89,585 | 57,785 | 50 K to 57.8 K (+15.57 %) |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Option Exercise | M | 2.45 | 7,500 | 18,375 | 47,500 | |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Option Exercise | M | 2.52 | 5,000 | 12,600 | 30,000 | |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Option Exercise | M | 2.81 | 550 | 1,546 | 0 | |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Sell | S | 11.53 | 13,050 | 150,500 | 50,000 | 63.1 K to 50 K (-20.70 %) |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Buy | M | 11.53 | 13,050 | 150,500 | 63,050 | 50 K to 63.1 K (+26.10 %) |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Option Exercise | M | 2.45 | 5,000 | 12,250 | 45,000 |